Treatment of children from 6 to 11 years old affected by moderate–severe atopic dermatitis with dupilumab: a first perspective from a single‐center real‐life experience in Italy. (3rd February 2022) - Colonna, C.; Zussino, M.; Monzani, N.A.; Ponziani, A.; Cavalli, R.